Bexorg key facts
as of Oct 2026- Developer of a whole-brain perfusion technology designed to support brain research and therapy development.
- Bexorg is valued at approximately $160.0M as of Oct 2026 (last reported valuation).
- It has raised $42.5M; the latest was Early Stage VC ($23.0M) in Sep 2025.
- Notable investors include Connecticut Innovations, Amplify Partners, Engine Ventures, E1 Ventures, Starbloom Capital — 7 tracked in total.
- Status: Privately Held (backing).
Bexorg's last reported valuation, Sep 2025. Nothing priced has surfaced since.
- ·Watch Bexorg: the Monday email on marks, rounds and moves
Bexorg funding rounds
No funding rounds for Bexorg are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Bexorg valuation
Bexorg's last reported valuation was $160 million in Sep 2025. No priced round, secondary trade or fund mark has surfaced since.
Bexorg investors
7 investors are on record for Bexorg, including Connecticut Innovations, Amplify Partners, Engine Ventures and E1 Ventures. By type, the record holds 4 venture capital firms and 1 family office.
About Bexorg
Developer of a whole-brain perfusion technology designed to support brain research and therapy development. The company offers a proprietary technology capable of maintaining and monitoring intact human brains, enabling researchers and drug developers to conduct detailed studies of neurological conditions.
- Sector
- Healthcare
- HQ
- New Haven, CT, United States
- Founded
- 2021
- Employees
- 30
- Website
- bexorg.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.